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MAPKOvulated oocytes are arrested at themetaphase of secondmeiotic division. Themetaphase-II arrest inXenopus oo-
cytes is regulated by RSKs located downstream of theMos–MAPK pathway. In mice, other kinase(s) besides RSKs
may be responsible for the metaphase-II arrest, because RSK1/RSK2/RSK3-triple knockout mice exhibit no obvi-
ous phenotype. Here, we show the subcellular localization and possible role of mitogen- and stress-activated ki-
nase 1, MSK1 known as another downstream kinase of the Mos–MAPK pathway, in the mouse oocytes.
Immunostaining analysis indicated that MSK1 is present in the germinal vesicle (GV) and cytoplasm of oocytes
at the GV and metaphase-II stages, respectively. An active, phosphorylated form of MSK1 was predominantly lo-
calized to the metaphase-II spindle. The inhibition of the MSK1 activity failed to maintain the sister chromatid
alignment within the metaphase-II plate. Importantly, MSK1 exhibited the ability to phosphorylate four Ser/Thr
residues of meiotic cell-cycle regulator EMI2. The phosphorylationwas required for up-regulation of the EMI2 ac-
tivity in the oocytes. These results suggest that mouse MSK1 may play a key role in the metaphase-II arrest
through phosphorylation of EMI2.
Crown Copyright © 2011 Published by Elsevier Inc. All rights reserved.Introduction
The meiotic cell cycle consists of two successive divisions: meiosis
I and meiosis II. Germinal vesicle (GV)-stage oocytes in many verte-
brates are arrested ﬁrst at the prophase of meiosis I and undergo mat-
uration after hormonal stimulation (Kishimoto, 2003; Sagata, 1996).
The mature oocytes are re-arrested by cytostatic factor CSF at the
metaphase of meiosis II (Masui and Markert, 1971). The metaphase-
II arrest of the oocytes is regulated by the Mos–MAPK pathway that
maintains the kinase activity of CDK1–cyclin B complex (maturation
promoting factor, MPF) at an elevated level (Perry and Verlhac,
2008; Tunquist and Maller, 2003). Following fertilization the kinase
activity of MPF is reduced owing to degradation of cyclin B, which
leads to release from the metaphase-II arrest of the oocytes.
F-box protein 43 (EMI2), a key component of CSF, is known to in-
hibit anaphase-promoting complex/cyclosome (APC/C) required for
degradation of cyclin B, and to cause the metaphase-II arrest in the
mouse and Xenopus oocytes (Madgwick et al., 2006; Schmidt et al.,
2005; Shoji et al., 2006; Tung et al., 2005). Both stability and activity
of Xenopus Emi2 in the metaphase-II arrest are up-regulated by
RSKs, 90-kDa ribosomal S6 kinases, located immediately downstream
of ERK1/2 MAPK (Bhatt and Ferrell, 2000; Gross et al., 2000; Inoue
et al., 2007; Nishiyama et al., 2007). RSKs possess the ability to. Baba).
11 Published by Elsevier Inc. All righphosphorylate four Ser/Thr residues of Xenopus Emi2 at positions
S335, T336, S342, and S344. Although RSKs are identiﬁed as the
ERK1/2 substrates (Kalab et al., 1996), the mouse oocytes lacking
three RSKs, RSK1, RSK2, and RSK3, exhibit the normal metaphase-II
arrest (Dumont et al., 2005). Thus, these ﬁndings raise the possibility
that other kinase(s) instead of RSKs may participate in phosphoryla-
tion of EMI2 in the mouse oocytes (Inoue et al., 2007; Suzuki et al.,
2010).
Mitogen- and stress-activated protein kinases, MSK1 and MSK2
(RPS6KA5 and RPS6KA4, respectively), are activated by ERK1/2 and/
or p38 MAPK following cellular stimulation in somatic cells (Deak et
al., 1998; Pearce et al., 2010; Wiggin et al., 2002). MSKs resemble
RSKs because these proteins belong to the AGC kinase subfamily,
and have two kinase domains connected by a regulatory linker re-
gion. However, the presence and function of MSKs in the mouse oo-
cytes still remain uncertain. In this study, we have focused on the
subcellular localization and function of MSK1 in the mouse oocytes.
Our data suggest that MSK1 may play a key role in phosphorylation
of EMI2 to maintain the metaphase-II arrest.
Materials and methods
Plasmids
DNA fragments encoding EMI2 (GenBank ID: NP_001074772.1),
MSK1 (GenBank ID: AAQ24165.1), and CREB (GenBank ID: NP_034082.
1) were ampliﬁed by PCR using a mouse ovary or testis cDNA library as
a template. The following sets of oligonucleotides were used as primers:ts reserved.
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GAGGCGTTTTAAGTTCCGC-3′ for EMI2; 5′-GCCTCGAGAGGGTGAAG-
ATGGAGGG-3′ and 5′-GCTCTAGAACATACCTCAGGCACATG-3′ for MSK1;
5′-GCGAATTCATGACCATGGAATCTGGAGC-3′ and 5′-GCCTCGAGAACT-
TAAATCCCAAATTAATC-3′ for CREB. The ampliﬁed fragments were in-
troduced into pcDNA3/FLAG-HA or pGEX-4T-1. To prepare pET-32a/
EMI2, pGEX-4T-1/EMI2, and pGEX-4T-1/EMI2 plasmids containing the
EMI2 sequences at residues 3–400, 3–400, and 204–383, respectively,
DNA fragments were PCR-ampliﬁed from pcDNA3/FLAG-HA/EMI2 as a
template, and introduced into the vectors. pcDNA3.1-poly(A)/FLAG-
HA/EMI2 plasmid was prepared by introducing the KpnI/BamHI frag-
ment of pcDNA3/FLAG-HA/EMI2 into pcDNA3.1-poly(A), as described
previously (Yamazaki et al., 2007). In vitro site-directed mutagenesis
was carried out according to themanufacturer′s protocol (Agilent Tech-
nology, Santa Clara, CA).
Reverse transcription-PCR
First-strand cDNAwas synthesized from total RNA ofmouse oocytes
using a SuperScript™ III First-Strand Synthesis system (Invitrogen,
Carlsbad, CA). DNA was ampliﬁed by PCR using an Advantage
cDNA Polymerase Mix (Clontech, Mountain View, CA). The following
sets of oligonucleotides were used as primers: 5′-GCTACTAAC-
TGGAGCATCTCCTTTC-3′ and 5′-TCAAGAGACGCTGAAGTAGGTCTT-3′
for MSK1; 5′-GAGATGTTCACTCACCTCTACCAG-3′ and 5′-TGAGT-
CAAGTAAGACGTTCTCCAG-3′ for MSK2; 5′-AAAAGCTTGGCGCTTTT-
GACTCAGGA-3′ and 5′-GGAATTCAAGTCAGTGTACAGGCCAG-3′ for
ACTB (β-actin). The reaction program consisted of 40 cycles of
94 °C for 30 s, 62 °C for 30 s, and 68 °C for 45 s.
Antibodies
His-tagged recombinant protein of mouse EMI2 containing the
amino acid sequence at positions 3–400 was produced in Escherichia
coli BL21 (DE3), as described previously (Kim et al., 2005; Shoji
et al., 2006). The recombinant protein was puriﬁed on a Ni-NTA His
column (Novagen, Madison, WI), emulsiﬁed with Freund's complete
(Difco Laboratories, Detroit, MI) or incomplete adjuvant (Wako,
Osaka, Japan), and injected into female New Zealand White rabbits
(SLC, Shizuoka, Japan). Anti-EMI2 antibodywas puriﬁed on a Sepharose
4B column previously coupled with glutathione S-transferase (GST)-
tagged EMI2, as described previously (Baba et al., 1994). Anti-cyclin
B1, anti-phosphorylated MSK1, and anti-phosphorylated ERK1/2 anti-
bodies were purchased from Cell Signaling Technology (Danvers, MA),
and anti-ACTB and anti-TUBB1 (β-tubulin) antibodies were from
Sigma-Aldrich (Saint Louis,MO). Anti-MSK1monoclonal (Cell Signaling
Technology) and polyclonal (Santa Cruz Biotechnology, Santa Cruz, CA)
antibodies were mainly used for immunoblot and immunostaining
analysis, respectively. Horseradish peroxidase-conjugated antibodies
against mouse, rat, or rabbit IgG were purchased from Jackson Immu-
noresearch Laboratories (West Grove, PA). Alexa Fluor 488- or 568-
conjugated antibodies against rat, mouse or rabbit IgG were purchased
fromMolecular Probes (Eugene, OR). All animal experiments were per-
formed ethically, and experimentationwas in accordwith the Guide for
the Care and Use of Laboratory Animals at University of Tsukuba.
Oocyte collection and microinjection
The GV-stage oocytes were collected from ovaries of 8- to 9-week-
old ICR mice (SLC) 46–48 h after intraperitoneal injection of pregnant
mare's serum gonadotropin (Aska Pharmaceutical, Tokyo, Japan). The
oocytes were put in a drop of KSOM (Lawitts and Biggers, 1993) con-
taining 10 mM HEPES and 0.24 mM N6, 2′-O-dibutyryladenosine 3′:5′-
cyclic monophosphate, (dbcAMP; Sigma-Aldrich). cRNAs (40 ng/μl)
and 4 mM MSK1 morpholino oligonucleotide (MO; CCTCCCCCTCCAT-
CTTCACCCTCTT, Gene Tools, Philomath, OR) were microinjected intothe oocytes using a Femtojet constant ﬂow system (Eppendorf,
Hamburg, Germany). The oocytes were cultured in TYH medium
(Toyoda et al., 1971) containing bovine serum albumin (BSA; 4 mg/ml).
Immunoblot analysis
Proteins were separated by SDS-PAGE and transferred onto
Immobilon-P polyvinylidene diﬂuoride membranes (Millipore,
Bedford, MA). The blots were blocked with 20 mM Tris/HCl, pH
7.5, containing 5% skim milk or BSA, 0.1% Tween-20, and 0.15 M
NaCl, incubated with primary antibodies, and then treated with sec-
ondary antibodies conjugated with horseradish peroxidase. The im-
munoreactive proteins were visualized by using an ECL detection
system (GE Healthcare, Piscataway, NJ).
Immunostaining analysis
Mouse ovarian and oviductal tissues were ﬁxed in 4% paraformalde-
hyde at 4 °C overnight, embedded in parafﬁn, and sliced into 5-μm sec-
tions. The sections were treated with 10 mM Tris/HCl, pH 8.0,
containing 1 μg/ml proteinase K, and 1 mM EDTA at 37 °C for 30 min,
boiled in 10 mM trisodium citrate dihydrate and 10 mMcitric acidmono-
hydrate for 5 min, and then treated with phosphate buffered saline, PBS,
containing 1% Triton X-100 at 4 °C for 20 min. The sections were blocked
with PBS containing 3% goat serum and 0.05% Tween-20 at room temper-
ature for 60 min, incubated with primary antibodies, reacted with sec-
ondary antibodies conjugated with Alexa Fluor 488 or 568 at room
temperature for 60 min, counterstained with Hoechst 33342, and then
viewed under an IX71 ﬂuorescence microscope (Olympus, Tokyo,
Japan), as described previously (Kimura et al., 2009).
RNA synthesis in vitro
RNAs were synthesized by T7 polymerase using a RiboMAX large
scale RNA production system-T7 kit (Promega, Madison, WI). The
RNAs were treated with RQ1 RNase-free DNase (Promega) at 37 °C
for 20 min, extracted with phenol/chloroform, precipitated with eth-
anol, dissolved in 10 mM Tris/HCl, pH 7.4, containing 0.1 mM EDTA,
applied to MicroSpin G-25 columns (GE Healthcare), and stored at
−80 °C.
Cell culture and immunoprecipitation
HEK293T cells were cultured in Dulbecco's modiﬁed Eagle's medium
(Wako) supplemented with 10% fetal bovine serum, 100 U/ml penicillin,
and 0.1 mg/ml streptomycin at 37 °C under 5% CO2 in air. Cells were
transfected with expression plasmid encoding FLAG–HA-tagged MSK1
using a PerFectin transfection reagent (Genlantis, San Diego, CA). After
48-h incubation, cells were cultured in serum-free medium for 24 h,
and then treated with 1 μM TPA, 12-O-tetradecanoylphorbol 13-acetate
(LC Laboratories, Woburn, MA) for 60min. Cells were lysed with
25 mM Tris/HCl, pH 7.5, containing 0.15 M NaCl, 0.1% SDS, 1% NP-40,
1 mM EDTA, 1 μg/ml aprotinin, 1 μg/ml pepstatin, 1 μg/ml leupeptin,
50 μg/ml PMSF, 1 mM DTT, 20 mMNaF, and 0.5 mM Na3VO4. The cell ly-
sates containing recombinantMSK1were subjected to immunoprecipita-
tion using anti-FLAGM2 agarose beads (Sigma-Aldrich). The purity of the
recombinant protein was evaluated by SDS-PAGE (Fig. S1).
In vitro kinase assay
The assays were carried out in 10 mM Tris/HCl, pH 7.5, contain-
ing 10 mM MgCl2, 0.1 mM DTT, 0.1 mM Na3VO4, 50 μM NaF, 10 μM
ATP, and 2.5 μCi [γ-32P]ATP (MP Biomedicals, Santa Ana, CA). GST-
tagged proteins (1 μg) were incubated with MSK1 (0.1 μg) puriﬁed
from HEK293T cells in the above buffer at 30 °C for 15 min, and
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liant blue (CBB) staining and autoradiography.Statistical analysis
Data are presented as mean values±S.E. (n=3). The Student's
t-test was used for statistical analysis; signiﬁcance was assumed
for pb0.05.Fig. 1. Expression and localization of mouse MSK1 and MSK2. (A) RT-PCR analysis. Total RNA
mice, and subjected to RT-PCR. (B) Immunoblot analysis. Whole protein extracts of GV- and
MSK1 (pMSK1), and β-tubulin. Mouse testicular and brain extracts (4 μg/lane) were also an
the GV- and MII-stage oocytes, respectively, were probed by using anti-ZP2 (green) and ant
dicates the GV. Scale bar=100 μm. (D) Presence of pMSK1 in the MII oocytes. Sections were
with Hoechst 33342. Note that pMSK1 is present only in the MII oocytes. (E) Localization of p
and anti-MSK1 or anti-pMSK1 (red) antibodies, and counterstained with Hoechst 33342.Results
Expression of Msk1 and Msk2 in mouse oocytes
Ubiquitous expression of Msk1 and Msk2 has been reported in
mouse tissues (Deak et al., 1998). We initially carried out RT-PCR
to examine expression of these two genes in the mouse oocytes
(Fig. 1A). Msk1 was expressed in the oocytes at the GV stage, and
the metaphase II-stage oocytes still contained Msk1 mRNA. Nos were prepared from the GV- and metaphase II (MII)-stage oocytes, ovary, and brain of
MII-stage oocytes (50 cells/lane) were analyzed using anti-MSK1, anti-phosphorylated
alyzed. (C) Immunostaining analysis. Mouse ovarian and oviductal sections containing
i-MSK1 (red) antibodies, and counterstained with Hoechst 33342 (blue). An arrow in-
probed by using anti-ZP2 (green) and anti-pMSK1 antibodies (red), and counterstained
MSK1 in the bipolar spindle. The MII oocytes were stained with anti-β-tubulin (green)
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immunoblot analysis indicated the presence of MSK1 in the GV- and
metaphase-II oocytes (Fig. 1B). Activation of human MSK1 requires
phosphorylation by ERK1/2 at S360, T581 and T700 (S359, T645 and
T824 in mouse MSK1, respectively) in somatic cells (Brami-Cherrier
et al., 2009). In this study, we used anti-phosphorylated MSK1 anti-
body that recognized phosphorylated T581 and T645 of human and
mouse MSK1, respectively. Interestingly, the phosphorylated form
of MSK1 was found only in the metaphase-II oocytes (Fig. 1B).
These data suggest that the mouse oocytes contain MSK1 that is ac-
tivated by phosphorylation after the GV stage during oocyte
maturation.
Subcellular localization of phosphorylated MSK1
When immunostaining analysis of ovarian and oviductal sections was
carried out, MSK1 was widely distributed in granulosa and cumulus cells
and the oocytes at the GV andmetaphase-II stages (Fig. 1C). In theGV and
metaphase-II oocytes, MSK1 was predominantly present in the GV and
cytoplasm, respectively. No signiﬁcant signal of phosphorylated MSK1
was found in the GV-stage oocytes, and granulosa and cumulus cells
(Fig. 1D). Importantly, phosphorylatedMSK1was distributed throughout
the cytoplasm of the metaphase II-stage oocytes, and was noticeably
enrichedwithin themetaphase-II plate. As comparedwith unphosphory-
lated MSK1, phosphorylated MSK1 was abundantly co-localized with β-
tubulin in the bipolar metaphase-II spindle (Fig. 1E). Thus, phosphorylat-
ed MSK1 may function in bipolar spindle formation.Fig. 2. Phosphorylation of MSK1 through Mos–MAPK pathway. (A) Effect of U0126 on oocy
MEK1/2-speciﬁc inhibitor, U0126 (0.1 mM). After incubation, the ratio of oocytes at the GV,
parentheses indicate those of the oocytes examined. (B) Immunostaining analysis. The GV-
24 h, and stained with anti-β-tubulin (green) and anti-phosphorylated MSK1 (pMSK1, red)
prepared by incubation of the GV-stage oocytes in the presence (+) of 60 μM U0126 for 24 h
Proteins (50 oocytes/lane) were analyzed using anti-phosphorylated ERK1/2 (pERK1/2), anPhosphorylation of MSK1 through Mos–MAPK pathway
We next examined whether phosphorylation of MSK1 in the
metaphase-II oocytes is dependent on the Mos–MAPK pathway.
The GV-stage oocytes underwent spontaneous maturation for 24 h
in the presence of U0126, a potent inhibitor speciﬁc for MEK1/2 lo-
cated immediately upstream of ERK1/2 in the Mos–MAPK pathway
(Yu et al., 2007). Approximately 70% of total oocytes resumed the
meiotic cell cycle in the absence of the inhibitor, and were arrested
at the metaphase-II stage (Fig. 2A). In the presence of U0126, most
oocytes (71%) were maintained at the GV stage, and no metaphase-
II oocyte was found. As described previously (Tong et al., 2003), ap-
proximately 14% of the oocytes extruded large polar bodies and
formed no spindles (Fig. 2A and B). Moreover, the abnormal oocytes
containing large polar bodies possessed no phosphorylated forms of
ERK1/2 and MSK1 (Fig. 2C). These results suggest that MSK1 is phos-
phorylated by the Mos–MAPK pathway during oocyte maturation.
Involvement of MSK1 in metaphase-II arrest
To clarify the role of MSK1 in the metaphase-II arrest further, we
microinjected an Msk1 MO into the oocytes at the GV stage, which
were incubated for 12 h in the presence of dbcAMP and then matured
for 24 h in the absence of dbcAMP (Fig. S2). TheMsk1MO only partially
(approximately 40%) prevented the accumulation of MSK1 protein in
themetaphase II-stage oocytes, and failed to affect themetaphase-II ar-
rest. We also examined effects of two chemical inhibitors, H89 andte maturation. The GV-stage oocytes were cultured for 24 h with (+) or without (−) a
metaphase-II (MII), large polar body (LPB), and other stages was counted. Numbers in
stage oocytes were cultured in the absence (−) or presence (+) of 0.1 mM U0126 for
antibodies, and Hoechst 33342 (blue). (C) Immunoblot analysis. The LPB oocytes were
. The oocytes at the GV and MII stages were directly subjected to immunoblot analysis.
ti-pMSK1, and anti-β-tubulin antibodies.
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H89 and Ro31-8220 are commonly used to inhibit the activities of
PKA and PKC, respectively, these two chemicals are also known to inter-
ferewith theMSK1 activity (Espino et al., 2006; Kawaguchi et al., 2009).
When the metaphase-II oocytes were incubated with or without H89
for 6 h, the metaphase-II arrest was 15 and 93% released by the pres-
ence of 30 and 60 μM H89, respectively (Fig. 3A). In the case of 5 μM
Ro31-8220, the oocyteswere 97% released from themetaphase-II arrest
(Fig. 3B). We observed chromosome segregation and abnormal pronu-
clear formation 2 and 4 h after addition of 60 μM H89, respectively
(Fig. 3C). In the H89-treated oocytes, phosphorylatedMSK1was spread
throughout the cytoplasm, owing to the loss of bipolar metaphase-II
spindle (Fig. S3). Moreover, immunoblot analysis revealed that cyclin
B1 is dramatically degraded 2 h after incubation in the presence of
60 μMH89 (Fig. 3D). The levels of phosphorylated ERK1/2, phosphory-
latedMSK1, and EMI2 remained relatively constant throughout incuba-
tion. These results suggest that the inhibition of the kinase activity ofFig. 3. Involvement of MSK1 in the metaphase-II arrest. (A) Release from the metaphase-II (M
(0, 30, and 60 μM) for 6 h. The numbers in parentheses indicate those of the MII oocytes ex
incubated with or without MSK inhibitor Ro31-8220 (0, 1, and 5 μM). (C) Immunostaining
and then stained with Hoechst 33342 (blue) and anti-β-tubulin antibody (green). Scale bar
H89 (60 μM) for 0, 2, and 4 h, and proteins (30 oocytes/lane) were analyzed using antibo
EMI2, cyclin B1, and β-actin.phosphorylated MSK1 by H89 may result in the failure of EMI2 phos-
phorylation/activation, leading to the degradation of cyclin B1.
Phosphorylation of EMI2 by MSK1
To ascertain the possibility that MSK1 directly phosphorylates
EMI2 to maintain the metaphase-II arrest, we carried out kinase as-
says in vitro using GST-fused proteins (Fig. 4). In Xenopus, four Ser/
Thr residues of Emi2 at positions S335, T336, S342, and S344 are
phosphorylated by RSKs (Inoue et al., 2007; Nishiyama et al.,
2007). This phosphorylation is required for up-regulation of the
stability and activity of Emi2 in the oocytes. Since these four resi-
dues of Xenopus Emi2 are conserved in the mouse, human, and zeb-
raﬁsh counterparts (Fig. 4A), it is assumed that mouse MSK1 as well
as Xenopus RSKs is capable of phosphorylating the same Ser/Thr res-
idues of EMI2. We thus prepared phosphorylated MSK1 from
HEK293T cells that had been cultured with TPA (Figs. S1 and S4),II) arrest by H89. The MII oocytes were incubated with or without MSK1 inhibitor H89
amined. *pb0.05. (B) Release from the MII arrest by Ro31-8220. The MII oocytes were
analysis. The MII oocytes were incubated in the presence of H89 (60 μM) for 2 and 4 h,
=50 μm. (D) Immunoblot analysis. The MII oocytes were incubated in the presence of
dies against phosphorylated ERK1/2 (pERK1/2), anti-phosphorylated MSK1 (pMSK1),
Fig. 4. Phosphorylation of EMI2 by MSK1. (A) Alignment of the amino acid sequences of EMI2 among mouse, human, Xenopus, and zebraﬁsh. Gray boxes and asterisks indicate the
conserved residues and possible phosphorylation sites by Xenopus RSKs, respectively. The sequence of an EMI2/4A mutant is also aligned. (B) In vitro kinase assay. GST-tagged EMI2
(1 μg) was incubated with (+) or without (−) puriﬁed MSK1 (0.1 μg) in the presence of [γ-32P]ATP, separated by SDS-PAGE, and analyzed by autoradiography and CBB staining.
GST alone and GST-tagged CREB were used as negative and positive controls, respectively. An asterisk indicates background proteins. (C and D) Inhibition of MSK1 kinase activity.
Puriﬁed MSK1 was incubated with GST-tagged EMI2 in the absence and presence (0, 0.2, and 2 μM each) of H89 (C) or of Ro31-8220 (D). *pb0.05. (E) Phosphorylation of EMI2/4A
by MSK1. Wild-type (WT) EMI2 and EMI2/4A were incubated with (+) or without (−) MSK1. *pb0.05.
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tein. Both EMI2 and transcription factor CREB (Deak et al., 1998)
as a positive control were efﬁciently phosphorylated by MSK1
(Fig. 4B). Phosphorylation of EMI2 by MSK1 was 34 and 87% inhib-
ited by addition of 0.2 and 2 μM H89 (74 and 87% for 0.2 and 2 μM
Ro31-8220), respectively (Fig. 4C and D). We further examined
whether MSK1 phosphorylates four Ser/Thr residues of EMI2 at
S326, T327, S333, and S335 (Fig. 4E). A GST-tagged EMI2 mutant
protein, termed EMI2/4A, in which these four Ser/Thr residues
were all substituted with Ala (Fig. 4A), was analyzed by in vitro ki-
nase assays. The EMI2/4A mutant was barely phosphorylated by
MSK1 as compared to wild-type EMI2 (Fig. 4E). Thus, MSK1possesses the ability to phosphorylate S326, T327, S333, and S335
on the EMI2 molecule.
Up-regulation of EMI2 activity by S326, T327, S333, and S335 phosphorylation
Ala substitutions of S335 and T336 or T336, S342, and S344 in Xenopus
Emi2have beendemonstrated to result in protein degradation dependent
of E3 ubiquitin ligase SCFβ-TrCP during oocyte maturation (Inoue et al.,
2007; Nishiyama et al., 2007). SCFβ-TrCP recognizes the phosphodegron
sequence, Asp-Ser-Ala-Phe-His-Ser, of Xenopus Emi2 at residues 283–
288. Because the Xenopus phosphodegron sequence is conserved in the
mouse EMI2 sequence, Asp-Ser-Gly-Phe-Cys-Ser, at residues 274–279,
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rying Ala substitutions at S275 and S279, and an EMI2/DSG/4A mutant.
To examine the inhibitory activities of these two EMI2 mutants toward
APC/C in an experimental model system (Suzuki et al., 2010), we micro-
injected synthetic RNA encoding HA-tagged EMI2/DSG or EMI2/DSG/4A
mutant into the GV-stage oocytes containing a negligibly small amount
of endogenous EMI2 (Madgwick et al., 2006; Shoji et al., 2006). The
RNA-injected oocytes were cultured in the presence of dbcAMP for 2 h,
and then underwent spontaneous maturation in the absence of dbcAMP
for 20 h (Fig. 5A). Exogenously expressed EMI2 is known to induce the
metaphase-I arrest under these conditions (Suzuki et al., 2010). Immu-
nostaining analysis using anti-HA antibody veriﬁed production of EMI2/
DSG and EMI2/DSG/4A mutant proteins in the oocytes after the 20-h in-
cubation (Fig. 5B). Importantly, the oocytes containing the EMI2/DSGpro-
tein were mostly (84%) arrested at the metaphase-I stage, whereas a
signiﬁcantly low level (43%) of the metaphase-I arrest was found in theFig. 5. EMI2 activity is up-regulated by phosphorylation at S326, T327, S333 and S335. (A)
stage oocytes were microinjected with polyadenylated RNA encoding HA-tagged EMI2/DSG
ence of dbcAMP for 2 h. After incubation in the absence of dbcAMP for 20 h, the oocytes at d
the oocytes contain a negligibly small amount of endogenous EMI2 until the MI/MII transiti
body (red). Fluorescence intensities of the oocytes expressing HA-tagged DSG or DSG/4A (15
of oocytes at GV, MI, and MII stages. Numbers in parentheses indicate those of the oocytes ex
Emi2 activity in the Xenopus oocytes. In the mouse oocytes, the EMI2 activity may be reg
completely.oocytes containing the EMI2/DSG/4A protein (Fig. 5C). In contrast, 40%
of total EMI2/DSG/4A-containing oocytes underwent meiotic maturation
and progressed to the metaphase-II stage. Since endogenously produced
MSK1 was phosphorylated in the EMI2/DSG-containing oocytes arrested
at the metaphase-I stage (Fig. S5), the phosphorylation of EMI2 at S326,
T327, S333, and S335 is probably required for the metaphase-I arrest of
the oocytes. Thus, MSK1 may be involved in the metaphase-II arrest
through phosphorylation of EMI2 in the mouse. On the basis of the data
obtained, we propose a schematic model for the metaphase-II arrest in
the mouse oocyte (Fig. 5D).
Discussion
This study describes the subcellular localization and possible role
of MSK1 in the metaphase-II arrest of the mouse oocyte. Two MSKs,
MSK1 and MSK2, are ubiquitously expressed and predominantly lo-Experimental protocol for expression of EMI2/DSG and EMI/DSG/4A mutants. The GV-
and EMI2/DSG/4A (termed DSG and DSG/4A, respectively), and incubated in the pres-
ifferent maturation stages were counted. MI, metaphase I; MII, metaphase II. Note that
on. (B) Immunostaining analysis. The oocytes were immunostained with anti-HA anti-
cells each) were measured. Arrows indicate polar bodies. Scale bar=100 μm. (C) Ratio
amined. (D) Schematic model for the MII arrest in the mouse oocytes. RSKs regulate the
ulated predominantly by MSK1, although participation of RSKs cannot be neglected
80 Y. Miyagaki et al. / Developmental Biology 359 (2011) 73–81calized in the cell nucleus (Deak et al., 1998). Of these two MSKs, only
MSK1 is present in the GV and cytoplasm of oocytes at the GV and
metaphase-II stages, respectively (Fig. 1). MSK1 is changed to the ac-
tive form by Ser/Thr phosphorylation after the GV stage, and the
phosphorylated protein is enriched in the bipolar spindle in the
metaphase-I/II oocytes (Figs. 1 and S5). In addition, phosphorylated
MSK1 is capable of phosphorylating four Ser/Thr residues of EMI2
(Fig. 4), which is required for the CSF arrest (Fig. 5). These ﬁndings
suggest that MSK1 may play a key role in the metaphase-II arrest of
oocytes through phosphorylation of EMI2 in the mouse. It is impor-
tant to note that consistent with previous data regarding the localiza-
tion of ERK1/2 (Fan et al., 2009; Sasseville et al., 2010), MSK1 is also
localized in granulosa and cumulus cells (Fig. 1). This observation im-
plies a functional role of MSK1 in these cells.
Phosphorylated MSK1 is abundantly present in the bipolar spindle of
metaphase-I/II oocytes (Figs. 1 and S5), as described above. ERK1/2 are
thought to phosphorylate MSK1 as a target protein in somatic cells
(Deak et al., 1998). In themouse oocytes, phosphorylation of ERK1/2 is di-
rectly catalyzed by MEK1/2 that are activated by Mos (Verlhac et al.,
1996), as shown in Fig. 5D. Indeed, both the inhibition of ERK1/2 activa-
tion by the MEK inhibitor U0126 (Tong et al., 2003) and the deletion
of Mos (Colledge et al., 1994; Hashimoto et al., 1994) have been reported
to induce to release themetaphase-II arrest. Since ERK1/2 are activated by
MEK1/2 immediately after GV breakdown in themouse oocytes (Tsurumi
et al., 2004), activation ofMSK1probably takes place successively through
phosphorylation by ERK1/2 (Fig. 2). Phosphorylated MSK1 may then act
on activation of EMI2 present in the bipolar spindle (Suzuki et al.,
2010). It is also suggested that phosphorylated MSK1 may function in
phosphorylation of unknown target protein(s) localized in the oocyte
spindle. Indeed, the loss of active ERK1/2 has been reported to result in
the abnormal shape of bipolar spindle, because of no activation of
the ERK1/2 substrates, including MISS and DOC1R (Lefebvre et al., 2002;
Terret et al., 2003).
MO is conventionally utilized to inhibit production of target pro-
teins in the mouse oocytes; however, accumulation of some proteins
present in the GV-stage oocytes is not entirely prevented by MO
(Chang et al., 2009; Yuan et al., 2010). In the present study, despite
injection ofMsk1MO into the GV-stage oocytes, theMsk1 knockdown
oocytes still contained a relatively large amount of MSK1 after meiotic
resumption, and failed to affect the meiotic arrest at the metaphase-II
stage (Fig. S2). This phenotype may be due to the possibility that
MSK1 accumulation in the GV-stage oocytes is abundant enough for
progression to the metaphase-II stage.
H89 acts as inhibitors of PKA and MSK1, whereas the activities of
MSK1, RSKs, and PKC are predominantly inhibited by Ro31-8220
(Davies et al., 2000; Oh et al., 2010). PKA is thought to participate
in meiotic arrest only at the prophase of meiosis I in the vertebrate
oocytes (Perry and Verlhac, 2008). In this study, the above-
mentioned two inhibitors, H89 and Ro31-8220, induce to release
the metaphase-II arrest (Fig. 3). Our data imply that at least MSK1
is involved in the metaphase-II arrest of mouse oocytes. This possi-
bility appears to be supported by the fact that the RSK1/RSK2/RSK3
triple- and MSK1/MSK2 double-knockout mice both display no
overt phenotype (Dumont et al., 2005; Wiggin et al., 2002). Thus,
we speculate that MSK1 and RSKs may serve as a compensatory
mechanism to activate/phosphorylate EMI2 in the mouse oocytes
(Fig. 5D).
Both MSKs and RSKs are known to phosphorylate Ser/Thr resi-
dues in the conserved R/KXRXXS, RRXS, and RKS motifs (Hauge and
Frodin, 2006). In some experiments, we examined whether mouse
RSK1 possesses the ability to phosphorylate EMI2 (Fig. S6). Our
data demonstrated that MSK1 and RSK1 are both capable of directly
phosphorylating S326, T327, S333, and S335 of mouse EMI2 (Figs. 4
and S6). When an EMI2/2A mutant carrying Ala substitutions at
S326 and T327 was analyzed by in vitro kinase assays, MSK1 phos-
phorylated the Ser residues at positions 333 and 335 (Fig. S7).Since MSK1 fails to phosphorylate EMI2/4A mutant (Fig. 4E), either
one or both of S333 and S335, in addition to S326 and T327, in the
EMI2 molecule may be phosphorylated by MSK1. It is intriguing
that the amino acid sequences carrying S333 and S335 contain no
consensus motifs of phosphorylation sites by MSKs. Thus, further ex-
periments are required to elucidate the detailed mechanism on
MSK1-catalyzed phosphorylation of EMI2.
Since initial characterization of CSF (Masui and Markert, 1971),
progress has been made in understanding the role of CSF in the oo-
cytes at the molecular level. Recently, Xenopus Emi2 has been
reported to be indispensable for the CSF activity in the Mos–MAPK
pathway (Inoue et al., 2007; Nishiyama et al., 2007); the stabilization
and activation of Emi2 are promoted by its phosphorylation cata-
lyzed by RSKs. Because RSKs are not essential for the metaphase-II
arrest in the mouse oocytes (Dumont et al., 2005), it has long been
believed that other kinase(s) participates in phosphorylation of
EMI2. Our data presented here emphasize that MSK1 is a candidate
protein involved in phosphorylation of EMI2. Thus, this study pro-
poses a novel model for direct phosphorylation of EMI2 by MSK1 in
the Mos–MAPK pathway of the mouse oocyte.Acknowledgments
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